GLP-1 weight-loss medications, explained
A straight, physician-written guide to the drugs everyone is talking about — semaglutide, tirzepatide, the compounded-versus-brand question, oral options, and what's still in the pipeline.
What these medications actually do
GLP-1 medications started as diabetes drugs and turned into the most effective weight-loss treatment most people have ever had access to. The class is named for the gut hormone it copies, glucagon-like peptide-1. You almost certainly know the brand names: Ozempic and Wegovy (both semaglutide), Mounjaro and Zepbound (both tirzepatide).
They work by mimicking hormones your gut releases after a meal. That slows how fast your stomach empties, steadies blood sugar, and quiets the appetite signals in the brain that drive hunger and food noise. The result shows up on the scale. In the large semaglutide trials, people lost about 15% of their body weight on average; with tirzepatide, the highest dose pushed average loss past 20%. Those are numbers older weight-loss drugs never came close to.
The catch is that the details matter, and the market moved faster than most people could follow. There's compounded versus brand-name, injectable versus a new wave of pills, and a pipeline of next-generation drugs like retatrutide that may go further still. This library walks through all of it in plain language, so you can tell the marketing from the medicine before you decide anything.
Eight reads. Start anywhere.
A full walk-through of GLP-1 weight-loss medication, from how the drugs work to what's coming next. Each piece stands on its own. Read them in order, or jump to the one question you came here with.
Quick answers, before you dig in
The questions people ask first when they start looking into GLP-1 medications.
Start your visitDone reading?
Get a real plan.
A U.S.-licensed Vyta.co clinician reviews your health history, and when a GLP-1 medication is safe and appropriate, sends treatment to your pharmacy. Compounded or brand-name, no appointment, no waiting room.